Viral hepatitis

A 1994 interim report

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A variety of viruses cause many of the disorders that are recognized as acute and chronic liver diseases. Remarkable scientific advances achieved during the past two decades have lead to readily available accurate diagnostic tests for hepatitis viruses designated A through E. Effective vaccines have been developed to prevent hepatitis B and, more recently, hepatitis A. Heightened understanding of the pathogenesis of chronic hepatitis caused by hepatitis B and C suggests several promising therapeutic approaches. Interferon is the sole drug yet proven to be effective in the treatment of some patients with chronic hepatitis B and C. Newer antiviral agents that will be used alone or in combination are under development.

Original languageEnglish (US)
Pages (from-to)429-435
Number of pages7
JournalGastroenterology Clinics of North America
Volume23
Issue number3
StatePublished - 1994

Fingerprint

Hepatitis B
Hepatitis
Hepatitis A virus
Hepatitis A
Chronic Hepatitis B
Chronic Hepatitis C
Chronic Hepatitis
Hepatitis C
Routine Diagnostic Tests
Interferons
Antiviral Agents
Liver Diseases
Chronic Disease
Vaccines
Viruses
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Viral hepatitis : A 1994 interim report. / Maddrey, W. C.

In: Gastroenterology Clinics of North America, Vol. 23, No. 3, 1994, p. 429-435.

Research output: Contribution to journalArticle

@article{503c93885ad6438cb96d35c3412217f5,
title = "Viral hepatitis: A 1994 interim report",
abstract = "A variety of viruses cause many of the disorders that are recognized as acute and chronic liver diseases. Remarkable scientific advances achieved during the past two decades have lead to readily available accurate diagnostic tests for hepatitis viruses designated A through E. Effective vaccines have been developed to prevent hepatitis B and, more recently, hepatitis A. Heightened understanding of the pathogenesis of chronic hepatitis caused by hepatitis B and C suggests several promising therapeutic approaches. Interferon is the sole drug yet proven to be effective in the treatment of some patients with chronic hepatitis B and C. Newer antiviral agents that will be used alone or in combination are under development.",
author = "Maddrey, {W. C.}",
year = "1994",
language = "English (US)",
volume = "23",
pages = "429--435",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Viral hepatitis

T2 - A 1994 interim report

AU - Maddrey, W. C.

PY - 1994

Y1 - 1994

N2 - A variety of viruses cause many of the disorders that are recognized as acute and chronic liver diseases. Remarkable scientific advances achieved during the past two decades have lead to readily available accurate diagnostic tests for hepatitis viruses designated A through E. Effective vaccines have been developed to prevent hepatitis B and, more recently, hepatitis A. Heightened understanding of the pathogenesis of chronic hepatitis caused by hepatitis B and C suggests several promising therapeutic approaches. Interferon is the sole drug yet proven to be effective in the treatment of some patients with chronic hepatitis B and C. Newer antiviral agents that will be used alone or in combination are under development.

AB - A variety of viruses cause many of the disorders that are recognized as acute and chronic liver diseases. Remarkable scientific advances achieved during the past two decades have lead to readily available accurate diagnostic tests for hepatitis viruses designated A through E. Effective vaccines have been developed to prevent hepatitis B and, more recently, hepatitis A. Heightened understanding of the pathogenesis of chronic hepatitis caused by hepatitis B and C suggests several promising therapeutic approaches. Interferon is the sole drug yet proven to be effective in the treatment of some patients with chronic hepatitis B and C. Newer antiviral agents that will be used alone or in combination are under development.

UR - http://www.scopus.com/inward/record.url?scp=0028064915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028064915&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 429

EP - 435

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 3

ER -